# Nanosonics Limited (NNCSF)

> Healthcare · AU · Reports in AUD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NNCSF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 207.35M | $ 20.56M | $ 24.38M | $ 9.88M | $ 219.60M |
| 2024 | $ 187.35M | $ 16.96M | $ 28.24M | $ 9.17M | $ 189.03M |
| 2023 | $ 176.53M | $ 16.64M | $ 22.85M | $ 10.65M | $ 175.54M |
| 2022 | $ 161.46M | $ 11.62M | $ 11.00M | $ 11.45M | $ 151.39M |
| 2021 | $ 140.85M | $ 13.11M | $ 5.33M | $ 5.60M | $ 140.14M |
| 2020 | $ 114.24M | $ 7.11M | $ 10.20M | $ 2.07M | $ 130.35M |
| 2019 | $ 113.64M | $ 15.05M | $ 13.95M | $ 2.34M | $ 117.56M |
| 2018 | $ 89.20M | $ 13.30M | $ 4.02M | $ 737.0K | $ 101.67M |
| 2017 | $ 58.19M | $ 5.47M | $ 12.87M | $ 1.15M | $ 90.49M |
| 2016 | $ 102.77M | $ 35.68M | $ 19.96M | $ 1.54M | $ 81.01M |
| 2015 | $ 30.90M | $ -13.10M | $ -14.62M | $ 10.93M | $ 42.47M |
| 2014 | $ 34.91M | $ 2.82M | $ 1.99M | $ 8.18M | $ 22.09M |
| 2013 | $ 20.50M | $ -4.61M | $ -5.27M | $ 7.84M | $ 19.22M |
| 2012 | $ 3.11M | $ -4.24M | $ -2.71M | $ 0 | $ 18.21M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.04 |
| Liabilities / Eq | 0.27 |
| Current Ratio | 6.38 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 0.64 |
| Gross Debt / FCF | 0.65 |

## Other views

- [Metrics](https://sponda.capital/en/NNCSF.md)
- [Charts](https://sponda.capital/en/NNCSF/charts.md)
- [Compare](https://sponda.capital/en/NNCSF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.